 |
crizotinib |
|---|---|
| Trade Name | Xalkori |
| Orphan Indication | Anaplastic large cell lymphoma |
| USA Market Approval | USA |
| USA Designation Date | 2012-09-28 00:00:00 |
| Sponsor | Pfizer, Inc.;10646 Science Center Drive;San Diego, California, 92121 |
| |
crizotinib |
|---|---|
| Trade Name | Xalkori |
| Orphan Indication | Anaplastic large cell lymphoma |
| USA Market Approval | USA |
| USA Designation Date | 2012-09-28 00:00:00 |
| Sponsor | Pfizer, Inc.;10646 Science Center Drive;San Diego, California, 92121 |